Audit 306067

FY End
2023-12-31
Total Expended
$2.32B
Findings
0
Programs
13
Organization: The Mitre Corporation (MA)
Year: 2023 Accepted: 2024-05-13

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
12.RD Department of Defense $1.17B Yes 0
93.RD Department of Health and Human Services $281.71M Yes 0
97.RD Department of Homeland Security $201.18M Yes 0
99.RD Usgc/special Projects (classified) $199.46M Yes 0
20.RD Department of Transportation - Federal Aviation Administration $166.24M Yes 0
21.RD Department of the Treasury - Irs $144.66M Yes 0
64.RD Veterans Administration $112.09M Yes 0
11.RD Department of Commerce - Nist $23.01M Yes 0
19.RD Department of State $15.27M Yes 0
12.RD Office of the Undersecretary of Defense-Jason Program Office $10.49M Yes 0
43.RD National Aeronautics and Space Administration $918,349 Yes 0
87.RD U.s. Consumer Product Safety Commission (cpsc) $491,356 Yes 0
81.RD Department of Energy $2,032 Yes 0

Contacts

Name Title Type
DMHDNDCPWUD1 Wilson Wang Auditee
7039837115 Laurie Warwick Auditor
No contacts on file

Notes to SEFA

Title: 1. Basis of Presentation Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) summarizes the federal expenditures of the Corporation to perform research and development activities for the federal government for the year ended December 31, 2023. The amounts reported as federal expenditures were obtained from the Corporation’s general ledger. Because the Schedule presents only a selected portion of the operations of the Corporation, it is not intended to and does not present the financial position, the results of its operations, or its cash flows of the Corporation. In accordance with the provisions of the Office of Management and Budget Uniform Guidance, Audits of States, Local Governments, and Non-Profit Organizations, the Corporation has one program, research and development cluster, and receives awards under that program. The Schedule includes all contracts and grants awarded to the Corporation under its program by agencies and departments of the federal government. Full Assistance Listing Numbers and pass-through numbers are not available for all grants or contracts on the Schedule. For the purpose of the Schedule, expenditures for federal award programs are recognized on the accrual basis of accounting. De Minimis Rate Used: Y Rate Explanation: MITRE utilizes billing rates that have been negotiated with the Corporate Administrative Contracting Office (CACO) and did not elect to use the 10% de minimis rate as covered in §200.414 Indirect (F&A) costs. The accompanying Schedule of Expenditures of Federal Awards (the Schedule) summarizes the federal expenditures of the Corporation to perform research and development activities for the federal government for the year ended December 31, 2023. The amounts reported as federal expenditures were obtained from the Corporation’s general ledger. Because the Schedule presents only a selected portion of the operations of the Corporation, it is not intended to and does not present the financial position, the results of its operations, or its cash flows of the Corporation. In accordance with the provisions of the Office of Management and Budget Uniform Guidance, Audits of States, Local Governments, and Non-Profit Organizations, the Corporation has one program, research and development cluster, and receives awards under that program. The Schedule includes all contracts and grants awarded to the Corporation under its program by agencies and departments of the federal government. Full Assistance Listing Numbers and pass-through numbers are not available for all grants or contracts on the Schedule. For the purpose of the Schedule, expenditures for federal award programs are recognized on the accrual basis of accounting.
Title: 2. Indirect Cost Rates Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) summarizes the federal expenditures of the Corporation to perform research and development activities for the federal government for the year ended December 31, 2023. The amounts reported as federal expenditures were obtained from the Corporation’s general ledger. Because the Schedule presents only a selected portion of the operations of the Corporation, it is not intended to and does not present the financial position, the results of its operations, or its cash flows of the Corporation. In accordance with the provisions of the Office of Management and Budget Uniform Guidance, Audits of States, Local Governments, and Non-Profit Organizations, the Corporation has one program, research and development cluster, and receives awards under that program. The Schedule includes all contracts and grants awarded to the Corporation under its program by agencies and departments of the federal government. Full Assistance Listing Numbers and pass-through numbers are not available for all grants or contracts on the Schedule. For the purpose of the Schedule, expenditures for federal award programs are recognized on the accrual basis of accounting. De Minimis Rate Used: Y Rate Explanation: MITRE utilizes billing rates that have been negotiated with the Corporate Administrative Contracting Office (CACO) and did not elect to use the 10% de minimis rate as covered in §200.414 Indirect (F&A) costs. MITRE utilizes billing rates that have been negotiated with the Corporate Administrative Contracting Office (CACO) and did not elect to use the 10% de minimis rate as covered in §200.414 Indirect (F&A) costs.